Symptoms and severity of Crohn’s Disease and Ulcerative Colitis can vary greatly between individuals.
Researchers at the University of Cambridge School of Clinical Medicine have now identified a gene expression profile that can divide patients with CD and UC into two otherwise undistinguishable subgroups — those with a high incidence of treatment-nonresponsive, frequently relapsing, or chronically active disease and those with mild disease.
This could help doctors and patients better determine the kind of treatment they may wish to pursue. This could be especially relevant if you are concerned about choosing between more aggressive medical therapies and/or more holistic approaches.
Read the report here.